Opus Capital Group’s Nu Skin NUS Stock Holding History

Opus Capital Group’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-6,608	Closed	-$367K	–	246
2017 Q1	$367K	Buy	+6,608	New	+$340K	0.05%	172

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PGP

Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return

Opus Capital Group's NUS Position: Q2 2017 in Review

Opus Capital Group sold out of Nu Skin (NUS) in Q2 2017, closing a stake of 6,608 shares — an estimated $367K sold.

Opus Capital Group first reported a position in NUS in Q1 2017 and held it in 1 quarter. The position peaked at $367K in Q1 2017. 266 funds tracked by Wall St. Rank hold NUS as of Q2 2017.

Opus Capital Group reported no remaining Nu Skin position as of Q2 2017 after selling out during the quarter.
Opus Capital Group sold 6,608 Nu Skin shares in Q2 2017, an estimated $367K.
Opus Capital Group first reported a position in Nu Skin in Q1 2017 and held it in 1 quarter.
Opus Capital Group's Nu Skin position peaked at $367K in Q1 2017.
266 funds tracked by Wall St. Rank held Nu Skin as of Q2 2017.

Based on Opus Capital Group's 13F filing for Q2 2017, filed 4 Aug 2017.